Navigation Links
Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
Date:10/11/2007

ARLINGTON, Va., Oct. 11 /PRNewswire/ -- The American Association of Health Freedom and the International Hyperbaric Medical Association announced today that physician-researchers at the Baromedical Research Institute and Louisiana State University School of Medicine, New Orleans have reported the successful treatment of chronic traumatic brain injury (TBI). The findings, published in Brain Research (2007 Oct 12;1174:120-9), are purportedly the first-ever demonstration of improvement of chronic brain injury in animals. The treatment involved a new application and drug dosage of hyperbaric oxygen therapy. Hyperbaric oxygen therapy has been applied to diving injuries, carbon monoxide poisoning, "flesh-eating bacteria," and chronic wounds. Application to chronic brain injury is controversial. This demonstration is a landmark achievement that reverses 100 years of neurology and the institutionalized belief that chronic brain injury in untreatable. It has significant implications for the treatment of chronic human traumatic brain injury (TBI) such as for current U.S. military veterans.

Lead author, Paul G. Harch, M.D., Clinical Assistant Professor, Director of the LSU School of Medicine Hyperbaric Medicine Fellowship in New Orleans, and author of recently published The Oxygen Revolution (Hatherleigh Press, NY), said that he made this discovery when he first applied HBOT to divers with a disabling form of "the bends," brain decompression illness. Harch noticed that the traditional application of a single HBOT to freshly injured divers did not result in the immediate cure described by the U.S. Navy. Instead, divers from the Gulf of Mexico presented days to weeks after their injury and required much more HBOT at a lower pressure. Eventually, he realized that they were treating more chronic forms of brain injury since the bubbles had long passed through the divers' brains. Harch and colleagues applied this lower dose of HBOT to patients with other forms of chronic brain injury, including trauma, cerebral palsy, autism, toxic brain injury, dementia, and multiple other diagnoses.

Harch stated that when he presented this human case experience at scientific meetings from 1992 to 1999 he was criticized for lack of an animal model. As a result, he adapted the Feeney model of acute traumatic brain injury to chronic brain injury and applied his human protocol of HBOT. Harch and colleagues were able to show in Brain Research that they could improve cognition (spatial learning and memory) while increasing blood vessel density in the damaged hippocampus of the rats.

The potential application to chronic human TBI is important because there is currently no treatment. Chronic TBI affects over 5 million Americans. Costs of treating TBI exceed $60 billion/year in the U.S. alone. The personal toll is far greater. Traumatic brain injury has also been described as the signature injury of the wars in Iraq and Afghanistan. As many as 400,000 U.S. servicemen have been exposed to blast injuries and could have varying degrees of TBI. Application of HBOT to these veterans could have a significant impact on their return to work, quality of life, and national security. For information on the Brain Injury Rescue and Rehabilitation Project, please visit http://www.healthfreedom.net.

Contact:

Brenna Hill, AAHF

Phone: 1.800.230.2762

Email: brenna@healthfreedom.net

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE American Association of Health Freedom
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
Breaking Medicine News(10 mins):